Since then, start-up activities of our FDCA Flagship Plant have commenced, and we anticipate producing the first FDCA in the coming months as we progress with the staged, safe start-up of the plant. We are confident that we have the right resources and skill sets in place to successfully start-up the FDCA Flagship Plant, enabling the commercial launch of FDCA and PEF.
As we prepare for commercial production of FDCA and PEF (branded as releaf®) in 2025, we have further focused on the development and execution of our commercial and licensing strategies, continuing to grow our extensive IP portfolio, and achieving key regulatory approvals, including the Food and Drug Administration approval of PEF for food contact applications in the United States. We have further diversified our feedstock options by developing a patented technology to convert polycotton textile waste into glucose and polyester, enabling fiber-to-fiber recycling.
